Preferred Label : Myasthenic syndrome, congenital, 4c, associated with acetylcholine receptor deficiency;
Symbol : CMS4C;
CISMeF acronym : CMS1D; CMS4C; FIM1;
Type : Phenotype, molecular basis known;
Alternative titles and symbols : FIM1; Myasthenic syndrome, congenital, type id; CMS1D; Cms id; Myasthenia, familial infantile, 1;
Description : Congenital myasthenic syndromes are genetic disorders of the neuromuscular junction
and can be classified by the site of the transmission defect: presynaptic, synaptic,
or postsynaptic. Presynaptic CMS with episodic ataxia (254210) is caused by mutation
in the CHAT gene (118490), and synaptic acetylcholinesterase (AChE) deficiency (603034)
is caused by mutation in the COLQ gene (603033). Postsynaptic disorders can be divided
into 2 kinetic defects, fast-channel (608930) and slow-channel (601462) CMS, and a
third disorder, AChR deficiency. Approximately 10% of CMS cases are presynaptic, 15%
are synaptic, and 75% are postsynaptic, the majority of which are caused by AChR deficiency
(Engel et al., 2003). See also CMS caused by mutation in the SCN4A sodium channel
gene (603967); familial limb-girdle myasthenic syndrome (254300), caused by mutation
in the DOK7 (610285) or agrin (AGRN; 103320) genes; and limb-girdle myasthenia with
tubular aggregates (610542), caused by mutation in the GFPT1 gene (138292) on chromosome
2p13. See also NOMENCLATURE below.;
Inheritance : Autosomal recessive;
Molecular basis : Caused by mutation in the cholinergic receptor, nicotinic, epsilon polypeptide gene
(CHRNE, 100725.0004);
Prefixed ID : #608931;
Origin ID : 608931;
UMLS CUI : C1837091;
Automatic exact mappings (from CISMeF team)
- fim 1 [MeSH Supplementary Concept]
CISMeF manual mappings
Currated CISMeF NLP mapping
DO Cross reference
Genes related to phenotype
HPO term(s)
ORDO concept(s)
Semantic type(s)
UMLS correspondences (same concept)
Validated automatic mappings to NTBT